Suppr超能文献

高龄人群中血压的预后意义。对治疗决策的影响。

Prognostic significance of blood pressure in the very old. Implications for the treatment decision.

作者信息

Bulpitt C J, Fletcher A E

机构信息

Division of Geriatric Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.

出版信息

Drugs Aging. 1994 Sep;5(3):184-91. doi: 10.2165/00002512-199405030-00004.

Abstract

A positive relationship between blood pressure and mortality at the age of 60 to 69 years becomes a negative relationship in men over the age of 75 years and in women over the age of 85 years, with hypertensive individuals living longer. This negative relationship in very old people probably reflects cardiac, respiratory and neoplastic disease in those with low blood pressure, and good myocardial function in those with high blood pressure. Therefore, in very elderly hypertensive people we cannot conclude that a reduction in blood pressure will not be beneficial, e.g. in reducing stroke events. However, the results of clinical trials of antihypertensive treatment in the elderly provide inadequate evidence to assess the benefit of treating hypertensive individuals over the age of 80 years. Randomly allocated controlled trials are required in this age group. The antihypertensive treatments that may be most suitable for the very elderly are diuretics with a beta-adrenergic blocking drug added if necessary. Angiotensin converting enzyme (ACE) inhibitors and calcium channel blockers have not, as yet, a proven role in the treatment of hypertension in the very old.

摘要

60至69岁人群中,血压与死亡率呈正相关,但在75岁以上男性和85岁以上女性中,这种关系变为负相关,高血压患者寿命更长。高龄人群中的这种负相关关系可能反映了低血压者存在心脏、呼吸和肿瘤疾病,而高血压者心肌功能良好。因此,对于高龄高血压患者,我们不能得出降低血压没有益处的结论,比如在减少中风事件方面。然而,老年人降压治疗的临床试验结果提供的证据不足,无法评估80岁以上高血压患者治疗的益处。这个年龄组需要随机分配的对照试验。最适合高龄者的降压治疗药物是利尿剂,必要时可加用β-肾上腺素能阻滞剂。血管紧张素转换酶(ACE)抑制剂和钙通道阻滞剂在高龄高血压治疗中尚未证实有明确作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验